Opinion

• Policy & Insight

Visiting the Bowelbabe Lab: Why tackling cancer must remain a government priority

Today, Michelle Mitchell, our chief executive, met Wes Streeting at the Bowelbabe Lab in the Crick Institute to discuss why cancer must remain a government priority Today, Michelle Mitchell, our chief executive, met Wes Streeting at the Bowelbabe Lab in the Crick Institute to discuss why cancer must remain a government priority

23 April 2025

• Health & Medicine
• Science & Technology

The ‘year of cancer vaccines’ confirms we are living in a golden age of cancer research

Michelle Mitchell reflects on how the growing promise of cancer vaccines shows that we are living in a golden age of cancer research Michelle Mitchell reflects on how the growing promise of cancer vaccines shows that we are living in a golden age of cancer research

30 December 2024

• Policy & Insight

What role can NHS scientists play in delivering the genomic revolution?

Alice Hilborn, policy advisor at Cancer Research UK, sits down with David Wells, chief executive at the Institute of Biomedical Science (IBMS), to understand the views of the IBMS on the future of genomic medicine, and the role healthcare scientists could play. Alice Hilborn, policy advisor at Cancer Research UK, sits down with David Wells, chief executive at the Institute of Biomedical Science (IBMS), to understand the views of the IBMS on the future of genomic medicine, and the role healthcare scientists could play.

10 December 2024

• Personal Stories
• Policy & Insight

When lung cancer killed my dad, the first thing I did was light up a cigarette

Gower Tan, Ambassador and Campaigns Officer at Cancer Research UK, shares the story of how his father's death from lung cancer helped inspire him to give up smoking Gower Tan, Ambassador and Campaigns Officer at Cancer Research UK, shares the story of how his father's death from lung cancer helped inspire him to give up smoking

17 October 2024

• Policy & Insight

What did party conference season mean for cancer?

Ian Caleb, public affairs manager, reviews the Liberal Democrat, Labour and Conservative party conferences and explains what they mean for cancer. Ian Caleb, public affairs manager, reviews the Liberal Democrat, Labour and Conservative party conferences and explains what they mean for cancer.

4 October 2024

• Policy & Insight

Why a focus on waiting time targets may neglect the poorest cancer patients

Naser Turabi, our director of evidence and implementation, explains why ensuring equitable access to cancer treatment is so crucial. Naser Turabi, our director of evidence and implementation, explains why ensuring equitable access to cancer treatment is so crucial.

22 July 2024

• Policy & Insight

Five priorities for the new Secretary of State for Health and Social Care 

Michelle Mitchell, our chief executive, explains how the new government can tackle cancer and help more people live longer, better lives. Michelle Mitchell, our chief executive, explains how the new government can tackle cancer and help more people live longer, better lives.

15 July 2024

• Policy & Insight

This election must be a turning point for cancer

Michelle Mitchell, our chief executive, explains why the upcoming general election must be a turning point for cancer Michelle Mitchell, our chief executive, explains why the upcoming general election must be a turning point for cancer

18 June 2024

• Policy & Insight

Abandoning the Tobacco and Vapes Bill would betray a generation

Michelle Mitchell, our chief executive, highlights the importance of the Tobacco and Vapes Bill being a top priority in all party manifestos Michelle Mitchell, our chief executive, highlights the importance of the Tobacco and Vapes Bill being a top priority in all party manifestos

28 May 2024

• Science & Technology

Cancer vaccines could be game changing, but they’re not a one-shot solution to beating cancer

Iain Foulkes, Executive Director of Research and Innovation at Cancer Research UK, reflects on today's news that Moderna and MSD’s melanoma cancer vaccine is moving to Phase 3 clinical trials Iain Foulkes, Executive Director of Research and Innovation at Cancer Research UK, reflects on today's news that Moderna and MSD’s melanoma cancer vaccine is moving to Phase 3 clinical trials

26 April 2024

• Policy & Insight

We’re calling on the UK Government to drive change. For Deborah

Alistair James, Dame Deborah James's father, shares why he and his family have written to party leaders ahead of the upcoming general election Alistair James, Dame Deborah James's father, shares why he and his family have written to party leaders ahead of the upcoming general election

25 April 2024

• Policy & Insight

A message to MPs: Don’t miss the opportunity to make smoking history

Ian Walker, executive director of policy, information and communications, shares his message to MPs and encourages them to help make smoking history Ian Walker, executive director of policy, information and communications, shares his message to MPs and encourages them to help make smoking history

26 March 2024